Patrick G. Lepore, Director at VYNE Therapeutics Inc. (VYNE), bought 12,500 shares at $7.41 ($93K) on 2021-03-15, disclosed to the SEC on 2021-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VYNE | BUY | 2023-03-22 | $50K | — | Filing → |
| LCI | BUY | 2022-11-14 | $49K | — | Filing → |
| LCI | BUY | 2022-05-17 | $27K | — | Filing → |